Anton Kontunen

Dr. Anton Kontunen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMarkus Karjalainen
Markus Karjalainen
AKAnton Kontunen
Anton Kontunen
SSSampo Saari
Sampo Saari
TRTopi Rönkkö
Topi Rönkkö
JLJukka Lekkala
Jukka Lekkala
NONiku Oksala
Niku Oksala
Electrosurgery produces surgical smoke. Different tissues produce different quantities and types of smoke, so we studied the particle characteristics of this surgical smoke in order to analyze the implications for the occupational health of the operation room personnel. We estimated the deposition of particulate matter (PM) from surgical smoke on the respiratory tract of operation room personnel using clinically relevant tissues from Finnish landrace porcine tissues including skeletal muscle, liver, subcutaneous fat, renal pelvis, renal cortex, lung, bronchus, cerebral gray and white matter, and skin. In order to standardize the electrosurgical cuts and smoke concentrations, we built a customized computer-controlled platform. The smoke particles were analyzed with an electrical low pressure impactor (ELPI), which measures the concentration and aerodynamic size distribution of particles with a diameter between 7 nm and 10 μm. There were significant differences in the mass concentration and size distribution of the surgical smoke particles depending on the electrocauterized tissue. Of the various tissues tested, liver yielded the highest number of particles. In order to better estimate the health hazard, we propose that the tissues can be divided into three distinct classes according to their surgical smoke production: 1) high-PM tissue for liver; 2) medium-PM tissues for renal cortex, renal pelvis, and skeletal muscle; and 3) low-PM tissues for skin, gray matter, white matter, bronchus, and subcutaneous fat.

1 January 2019 in Expert Systems with Applications
Verified
Journal Article
Closed access
PMPhilipp Müller
Philipp Müller
KSKatri Salminen
Katri Salminen
VNVille Nieminen
Ville Nieminen
AKAnton Kontunen
Anton Kontunen
MKMarkus Karjalainen
Markus Karjalainen
VSVeikko Surakka
Veikko Surakka

1 February 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MSMaiju Sutinen
Maiju Sutinen
AKAnton Kontunen
Anton Kontunen
MKMarkus Karjalainen
Markus Karjalainen
JKJuha Kiiski
Juha Kiiski
JHJill Hannus
Jill Hannus
NONiku Oksala
Niku Oksala

18 October 2016
Verified
Conference Paper
Closed access
VRVille Rantanen
Ville Rantanen
MIMirja Ilves
Mirja Ilves
AVAntti Vehkaoja
Antti Vehkaoja
AKAnton Kontunen
Anton Kontunen
JLJani Lylykangas
Jani Lylykangas
JLJukka Lekkala
Jukka Lekkala
A survey on the feasibility of surface electromyography (EMG) measurements in facial pacing is presented. Pacing for unilateral facial paralysis consists of the measurement of activity from the healthy side of the face and functional electrical stimulation to reanimate the paralyzed one. The goal of this study is to evaluate the feasibility of surface EMG as a measurement method to detect muscle activations and to determine their intensities. Prior work is discussed, and results from experiments where 12 participants carried out a set of facial movements are presented. EMG was registered from zygomaticus major (smile), orbicularis oris (lip pucker), orbicularis oculi (eye blink), corrugator supercilii (frown), and masseter (chew). Most important facial functions that are limited due to the paralysis are blinking, smiling, and puckering. With majority of the participants, crosstalk between the measured EMG channels was found to be acceptably small to be able to pace smiling and puckering based on detecting their contraction intensities from the healthy side. However, pacing blinking based on orbicularis oculi EMG measurement does not seem possible due to crosstalk from other muscles, but the electro-oculographic (EOG) signals that couple to the same measurement channel could help to detect eye blinks and trigger stimuli. Futhermore, masseter greatly disturbs EMG measurement of most facial muscles, which needs to be addressed in the pacing system to avoid falsely interpreting its activity as the activity of another muscle.

24 April 2018 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
AKAnton Kontunen
Anton Kontunen
MKMarkus Karjalainen
Markus Karjalainen
JLJukka Lekkala
Jukka Lekkala
ARAntti Roine
Antti Roine
NONiku Oksala
Niku Oksala

4 May 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
IHIlkka Haapala
Ilkka Haapala
AKAnton Kondratev
Anton Kondratev
ARAntti Roine
Antti Roine
MMMeri Mäkelä
Meri Mäkelä
AKAnton Kontunen
Anton Kontunen
JHJoonas Haapasalo
Joonas Haapasalo
Isocitrate dehydrogenase (IDH) mutation status is an important factor for surgical decision-making: patients with IDH-mutated tumors are more likely to have a good long-term prognosis, and thus favor aggressive resection with more survival benefit to gain. Patients with IDH wild-type tumors have generally poorer prognosis and, therefore, conservative resection to avoid neurological deficit is favored. Current histopathological analysis with frozen sections is unable to identify IDH mutation status intraoperatively, and more advanced methods are therefore needed. We examined a novel method suitable for intraoperative IDH mutation identification that is based on the differential mobility spectrometry (DMS) analysis of the tumor. We prospectively obtained tumor samples from 22 patients, including 11 IDH-mutated and 11 IDH wild-type tumors. The tumors were cut in 88 smaller specimens that were analyzed with DMS. With a linear discriminant analysis (LDA) algorithm, the DMS was able to classify tumor samples with 86% classification accuracy, 86% sensitivity, and 85% specificity. Our results show that DMS is able to differentiate IDH-mutated and IDH wild-type tumors with good accuracy in a setting suitable for intraoperative use, which makes it a promising novel solution for neurosurgical practice.